Status:
COMPLETED
A Study in People With Abnormal Fat Levels in the Blood
Lead Sponsor:
Eli Lilly and Company
Conditions:
Dyslipidemia
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The purposes of this study are to determine: * The safety of the study medication and any side effects that might be associated with it; * Whether the study medication can help patients with low leve...
Eligibility Criteria
Inclusion
- Men and women between 18 and 80 years of age
- People with abnormal fat levels in the blood (low HDL, high TG)
Exclusion
- People with diabetes
- People whose blood pressure is greater than 160/95 mm Hg, on or off blood pressure medicine
- People who have had frequent chest pain or unstable angina, a heart attack or a heart procedure, including stent placement, within the past 3 months
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00116519
Start Date
July 1 2005
End Date
October 1 2006
Last Update
January 26 2007
Active Locations (54)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
Hoover, Alabama, United States, 35216
2
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
Fayetteville, Arkansas, United States, 72703
3
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
San Diego, California, United States, 92128
4
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
Vista, California, United States, 92083